Colistin, rifampicin, and meropenem administered as single agents in a model of pneumonia caused by a carbapenem-resistant Acinetobacter baumannii

被引：4
|
作者：
Cassisa, Viviane [1 ,2 ]
Joly-Guillou, Marie-Laure [1 ,2 ]
Pailhories, Helene [1 ,2 ]
Coron, Noemie [2 ]
Eveillard, Matthieu [1 ,2 ]
机构：
[1] Grp Etude Interact Hotes Pathogenes, GEIHP, UPRES EA 3142, Corsica, France
[2] CHU Angers, Lab Bacteriol Hyg, F-49000 Angers, France
来源：
JOURNAL OF INFECTION | 2014年 / 69卷 / 05期
关键词：
EFFICACY; IMIPENEM;
D O I：
10.1016/j.jinf.2014.07.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：516 / +
页数：2
相关论文
共 50 条
  • [1] Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
    Song, Joon Young
    Lee, Jacob
    Heo, Jung Yeon
    Noh, Ji Yun
    Kim, Woo Joo
    Cheong, Hee Jin
    Hwang, In Sook
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (03) : 281 - 284
  • [2] Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
    Shi, HyeJin
    Lee, Jin Seo
    Park, So Yeon
    Ko, Yousang
    Eom, Joong Sik
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 3925 - 3934
  • [3] Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
    Aydemir, H.
    Akduman, D.
    Piskin, N.
    Comert, F.
    Horuz, E.
    Terzi, A.
    Kokturk, F.
    Ornek, T.
    Celebi, G.
    EPIDEMIOLOGY AND INFECTION, 2013, 141 (06): : 1214 - 1222
  • [4] Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
    Park, So Yeon
    Si, Hye Jun
    Eom, Joong Sik
    Lee, Jin Seo
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (12) : 5977 - 5985
  • [5] Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia
    Park, Jae-Min
    Yang, Kyung-Sook
    Chung, You-Seung
    Lee, Ki-Byung
    Kim, Jeong-Yeon
    Kim, Sun-Bean
    Sohn, Jang-Wook
    Yoon, Young-Kyung
    ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [6] In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii
    Abdul-Mutakabbir, Jacinda C.
    Yim, Juwon
    Nguyen, Logan
    Maassen, Philip T.
    Stamper, Kyle
    Shiekh, Zain
    Kebriaei, Razieh
    Shields, Ryan K.
    Castanheira, Mariana
    Kaye, Keith S.
    Rybak, Michael J.
    ANTIBIOTICS-BASEL, 2021, 10 (07):
  • [7] Clinical features and outcomes of carbapenem-resistant Acinetobacter baumannii pneumonia in the era of colistin
    Lee, Myung Goo
    RESPIROLOGY, 2024, 29 : 236 - 237
  • [8] In vitro antimicrobial activity of colistin in combination with rifampicin against carbapenem-resistant Acinetobacter baumannii
    Kongsanae, K.
    Naenna, P.
    Dhiraputra, C.
    Leelarasamee, A.
    Pongpech, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E421 - E422
  • [9] Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii
    Chiang, Shyh-Ren
    Chuang, Yin-Ching
    Tang, Hung-Jen
    Chen, Chi-Chung
    Chen, Chung-Hua
    Lee, Nan-Yao
    Chou, Chen-His
    Ko, Wen-Chien
    CRITICAL CARE MEDICINE, 2009, 37 (09) : 2590 - 2595
  • [10] In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii
    Song, Joon Young
    Kee, Sae Yoon
    Hwang, In Sook
    Bin Seo, Yu
    Jeong, Hye Won
    Kim, Woo Joo
    Cheong, Hee Jin
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 317 - 322
12345